Condition
Tattoo
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Completed4
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05515146CompletedPrimary
Lymphovascular Abnormalities Under Tattoos
NCT02877667Not ApplicableCompletedPrimary
Soliton Planar Acoustic Wave Device System for Dermal Clearing Human Trial Protocol
NCT01624688Not ApplicableCompletedPrimary
Optimizing Tattoo Removal: a Side-by-side Comparison in the Search for One Treatment Tattoo Removal
NCT02372786Phase 4CompletedPrimary
7% Lidocaine/7% Tetracaine Cream Versus 2,5% Lidocaine / 2,5% Prilocaine Cream
NCT00409162Not ApplicableUnknownPrimary
Safety and Efficacy Study of a New Device for Tattoo Removal
Showing all 5 trials